Gastroenterology

Gastroenterology

Volume 112, Issue 1, January 1997, Pages 40-45
Gastroenterology

A transforming growth factor beta 1 receptor type II mutation in ulcerative colitis-associated neoplasms

https://doi.org/10.1016/S0016-5085(97)70217-8Get rights and content

Abstract

BACKGROUND & AIMS: Numerous gastrointestinal tumors, notably sporadic and ulcerative colitis (UC)-associated colorectal carcinomas and dysplasias, gastric cancers, and esophageal carcinomas, manifest microsatellite instability. Recently, a transforming growth factor beta 1 type II receptor (TGF-beta 1RII) mutation in a coding microsatellite was described in colorectal carcinomas showing instability. One hundred thirty-eight human neoplasms (61 UC-associated, 35 gastric, 26 esophageal, and 16 sporadic colorectal) were evaluated for this TGF- beta 1RII mutation. METHODS: Whether instability was present at other chromosomal loci in these lesions was determined. In lesions manifesting or lacking instability, the TGF-beta 1RII coding region polydeoxyadenine (poly A) microsatellite tract was polymerase chain reaction amplified with 32P-labeled deoxycytidine triphosphate. Polymerase chain reaction products were electrophoresed on denaturing gels and exposed to radiographic film. RESULTS: Three of 18 UC specimens with instability at other chromosomal loci (17%) showed TGF- beta 1RII poly A tract mutation, including 2 cancers and 1 dysplasia; moreover, 2% of UC specimens without instability (1 of 43) (1 cancer), 81% of unstable sporadic colorectal cancers (13 of 16), and none of the 61 stable or unstable gastric or esophageal cancers contained TGF-beta 1RII mutations. CONCLUSIONS: Mutational inactivation of the poly A microsatellite tract within TGF-beta 1RII occurs early and in a subset of unstable UC neoplasms and commonly in sporadic colorectal cancers but may be rare in unstable gastric and esophageal tumors. (Gastroenterology 1997 Jan;112(1):40-5)

References (0)

Cited by (86)

  • Loss of MMR and TGFBR2 Increases the Susceptibility to Microbiota-Dependent Inflammation-Associated Colon Cancer

    2022, Cellular and Molecular Gastroenterology and Hepatology
    Citation Excerpt :

    The IBD-CRCs in VCMsh2/Tgfbr2 mice showed no Apc mutations either during spontaneous or DSS-induced colorectal tumorigenesis in contrast to the DSS-induced CRCs in VCMsh2 mice or SI tumors in both mouse lines. This is reminiscent of most IBD-CRCs in human patients that do not harbor APC mutations or seem to acquire them at later stages during tumor development and indicates that TGFBR2 loss at the early stages of tumorigenesis is crucial for their etiology or progression.15,17 However, other genes with known roles in intestinal homeostasis or colorectal tumorigenesis carried mutations in VCMsh2/Tgfbr2 CRCs.

  • Molecular basis of diseases of the gastrointestinal tract

    2018, Molecular Pathology: The Molecular Basis of Human Disease
  • Molecular Basis of Diseases of the Gastrointestinal Tract

    2009, Molecular Pathology: The Molecular Basis of Human Disease
View all citing articles on Scopus
View full text